trastuzumab deruxtecan

Trials studying trastuzumab deruxtecan

• phase3Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancerrecruitingn=686
• —Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancerrecruitingn=138
• phase1Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Canceractive not recruitingn=17
• phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancerrecruitingn=1,132
• phase2Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)recruitingn=450
• phase3A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)recruitingn=1,000
• phase2A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancernot yet recruitingn=27
• phase2Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spreadrecruitingn=768